Site icon pharmaceutical daily

Stada confirms postponing Board bidding session

STADA Arzneimittel building

STADA Arzneimittel building

Stada’s Supervisory Board has postponed expert sessions which were planned as part of the structured bidding process.

Stada confirmed media reports in a press release on Thursday saying that indicative bids do not yet reflect the fundamental value of the company and that it will wait for better offer.

In addition, Stada said that it objects current media reports that the delay in the process is aimed to make another committee composed of a private equity company and a strategic investor enter the process.

Exit mobile version